SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advanced Enzyme gains on completing additional investment of Rs 25 lakh in ANPL

08 Jun 2026 Evaluate

Advanced Enzyme Technologies is currently trading at Rs. 370.50, up by 3.50 points or 0.95% from its previous closing of Rs. 367.00 on the BSE.

The scrip opened at Rs. 361.50 and has touched a high and low of Rs. 372.25 and Rs. 358.85 respectively. So far 3452 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 419.80 on 11-May-2026 and a 52 week low of Rs. 251.90 on 30-Mar-2026.

Last one week high and low of the scrip stood at Rs. 419.80 and Rs. 352.00 respectively. The current market cap of the company is Rs. 4142.00 crore.

The promoters holding in the company stood at 43.26%, while Institutions and Non-Institutions held 30.90% and 25.84% respectively.

Advanced Enzyme Technologies has completed an additional investment of Rs 25 lakh in its wholly owned subsidiary -- Advanced Nutrazyme (ANPL) by way of investing in the rights issue of 2,50,000 Equity Shares of Rs 10 each. The investment will to be utilized by ANPL for its business and/or general corporate purposes.

With this, the investment of the company in ANPL has increased to Rs 30 lakh divided into 3,00,000 Equity Shares of Rs 10 each.

Advanced Enzymes Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.

Advanced Enzyme Share Price

366.00 -1.00 (-0.27%)
08-Jun-2026 15:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.90
Dr. Reddys Lab 1276.30
Cipla 1383.85
Zydus Lifesciences 1088.00
Lupin 2254.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×